MedAdvisor Partners with Apotex

Australian adherence software systems company MedAdvisor has partnered with Australia’s largest generic pharmaceutical company Apotex to enhance its exposure to the community pharmacy sector.  The marketing and distribution agreement will give MedAdvisor, which is in the process of raising capital in an Initial Public Offering, access to Apotex’s wide reaching pharmacy channels throughout the country.  Apotex Asia-Pacific md Roger
Millichamp said the partnership leverages the capabilities and strengths of each organisation “to deliver a relevant and important program to community pharmacy.” 

MedAdvisor CEO Robert Read highlighted that the company has more than 88,000 users and more than 1,250 pharmacies already on the platform and that the relationship with Apotex will increase the company’s community
pharmacy reach even further.  “Users of the MedAdvisor platform are 97% loyal to their favourite pharmacy and adherence is lifted by ~20%,” he said.  “In the face of PBS reform, improving loyalty and adherence is critical for pharmacy.”

Learn more about MedAdvisor with the education modules below.

Source: Pharmacydaily.com.au, Thursday 17 September 2015